Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome

The document reviewed the potential of using human follicular fluid (FF) in metabolomic analysis to better understand and diagnose polycystic ovary syndrome (PCOS), a condition affecting 5% to 20% of women worldwide. It highlighted that PCOS patients undergoing assisted reproductive techniques (ART) often experienced poor responses and low oocyte quality, leading to decreased fertilization success and increased miscarriages. Metabolomic analysis of FF was suggested to improve ART success prediction by quantifying proteins and peptides, aiding in embryo selection. The study also noted metabolic abnormalities in FF, such as altered lipid metabolites, which could impact oocyte quality and fertility. Despite advances in understanding PCOS through FF analysis, effective therapies were still lacking, indicating a need for further research.